Brain Scientific Inc. (BRSF) Offers Solutions for COVID-19 EEG Accessibility
Seizures have been common in hospitalized COVID-19 patients, and the death rate higher in those who experienced the seizures Due to a shortage of PPE and limited contact, EEG accessibility was limited during the pandemic The NeuroCap can fill the gap in EEG accessibility during the pandemic and into the future, as more long-term studies are created Brain Scientific (OTCQB: BRSF) is developing innovative and proprietary medical devices and software to bridge the widening gap in access to quality care. The Company’s first commercialized devices, the NeuroCap(TM) and NeuroEEG(TM), offer cost-effective and disposable substitutes to their traditional counterparts. The NeuroCap…